In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
深入研究IGM Biosciences的6條分析師建議
IGM Biosciences (NASDAQ:IGMS) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有6位分析師對IGM Biosciences（納斯達克股票代碼：IGMS）進行了分析，揭示了從看漲到看跌的不同觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for IGM Biosciences, presenting an average target of $16.17, a high estimate of $21.00, and a low estimate of $12.00. Marking an increase of 131.0%, the current average surpasses the previous average price target of $7.00.
在對12個月目標股價的評估中，分析師公佈了對IGM Biosciences的見解，平均目標股價爲16.17美元，最高估計爲21.00美元，低估值爲12.00美元。當前的平均價格上漲了131.0％，超過了之前的平均目標股價7.00美元。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
A comprehensive examination...
對金融...
登入免費觀看全文
登入/註冊